NCT02774564View on ClinicalTrials.gov

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Parkinson's Disease
Interventions
DRUG

BIA 3-202

Nebicapone tablets 50 mg, oral administration

DRUG

Placebo

Nebicapone matching placebo tablets

DRUG

Sinemet®

Sinemet® CR 200/50 (levodopa 200 mg / carbidopa 50 mg) tablets

Trial Locations (1)

4745-457

Human Pharmacology Unit, S. Mamede Do Coronado

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT02774564 - Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa | Biotech Hunter | Biotech Hunter